Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitis
Journal of Antimicrobial Chemotherapy · 05.01.2023 · 78 (1) · 276-283
DOI: 10.1093/jac/dkac389 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 22.11.2022. Verfasst von Katharine E Stott und 20 weiteren Autor:innen. Beteiligte Einrichtung: Antimicrobial Pharmacodynamics and Therapeutics, Department of Pharmacology, University of Liverpool, UK. Hauptthemen laut MEDLINE: Meningitis, Cryptococcal, Meningoencephalitis, Cryptococcus neoformans, HIV Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Wellcome Trust, Department of Health.
Abstract (Originalsprache)
Background
Single, high-dose liposomal amphotericin B (LAmB; AmBisome, Gilead Sciences) has demonstrated non-inferiority to amphotericin B deoxycholate in combination with other antifungals for averting all-cause mortality from HIV-associated cryptococcal meningitis. There are limited data on the pharmacokinetics (PK) of AmBisome. The aim of this study was to describe population PK of AmBisome and conduct a meta-analysis of the available studies to suggest the optimal dosing for cryptococcal meningoencephalitis.
Methods
Data from a Phase II and Phase III trial of high-dose, short-course AmBisome for cryptococcal meningoencephalitis were combined to develop a population PK model. A search was conducted for trials of AmBisome monotherapy and meta-analysis of clinical outcome data was performed.
Results
A two-compartment model with first-order clearance of drug from the central compartment fitted the data best and enabled the extent of inter-individual variability in PK to be quantified. Mean (SD) population PK parameter estimates were: clearance 0.416 (0.363) L/h; volume of distribution 4.566 (4.518) L; first-order transfer of drug from central to peripheral compartments 2.222 (3.351) h−1, and from peripheral to central compartment 2.951 (4.070) h−1. Data for the meta-analysis were insufficient to suggest optimal dosing of AmBisome for cryptococcal meningoencephalitis.
Conclusions
This study provides novel insight into the PK of AmBisome at the population level and the variability therein. Our analysis also serves to highlight the paucity of data available on the pharmacodynamics (PD) of AmBisome and underscores the importance of thorough and detailed PK/PD analysis in the development of novel antifungals, by demonstrating the challenges associated with post hoc PK/PD analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Antimicrobial Pharmacodynamics and Therapeutics, Department of Pharmacology, University of Liverpool, UK.
- Malawi Liverpool Wellcome Programme, Kamuzu University of Health Sciences, Malawi.
- Department of Medicine, Kamuzu University of Health Sciences, Malawi.
- Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.
- University of Botswana, Gaborone, Botswana.
- National Institute of Medical Research, Mwanza, Tanzania.
ORCID-Profile: Anne-Grete Märtson
Förderung
- Medical Research Council
- Wellcome Trust
- Department of Health
- Gilead Sciences through an Investigator Initiated Award
- European Developing Countries Clinical Trials Partnership
- Swedish International Development Cooperation Agency
- UKAID Joint Global Health Trials
- National Institute for Health Research
Zitieren
APA
Stott, K. E., Moyo, M., Ahmadu, A., Kajanga, C., Gondwe, E., Chimang'anga, W., Chasweka, M., Leeme, T. B., Molefi, M., Chofle, A., Bidwell, G., Changalucha, J., Unsworth, J., Jimenez-Valverde, A., Lawrence, D. S., Mwandumba, H. C., Lalloo, D. G., Harrison, T. S., Jarvis, J. N., …, & Märtson, A. G. (2023). Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitis. Journal of Antimicrobial Chemotherapy, 78(1), 276-283. https://doi.org/10.1093/jac/dkac389
Vancouver
Stott KE, Moyo M, Ahmadu A, Kajanga C, Gondwe E, Chimang'anga W, et al. Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitis. Journal of Antimicrobial Chemotherapy. 2023;78(1):276-283. doi:10.1093/jac/dkac389
BibTeX
@article{Stott2023,
author = {Stott, Katharine E and Moyo, Melanie and Ahmadu, Ajisa and Kajanga, Cheusisime and Gondwe, Ebbie and Chimang'anga, Wezzie and Chasweka, Madalitso and Leeme, Tshepo B and Molefi, Mooketsi and Chofle, Awilly and Bidwell, Gabriella and Changalucha, John and Unsworth, Jenny and Jimenez-Valverde, Ana and Lawrence, David S and Mwandumba, Henry C and Lalloo, David G and Harrison, Thomas S and Jarvis, Joseph N and Hope, William and Märtson, Anne-Grete},
title = {Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitis},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2023},
volume = {78},
number = {1},
pages = {276--283},
doi = {10.1093/jac/dkac389}
}
EUVIMED